[1]
«Study of patients diagnosed with Chronic Myelogenous Leukemia treated with STI 571 (Gleevec) in Ecuador», REMCB, vol. 28, n.º 1-2, pp. 7–10, ago. 2017, doi: 10.26807/remcb.v28i1-2.196.